Cargando…
PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer patients following such first-line treatments. Therefore, targeted therapy according to the molecular cancer biology can be very important in reducing...
Autores principales: | Taghehchian, Negin, Maharati, Amirhosein, Akhlaghipour, Iman, Zangouei, Amir Sadra, Moghbeli, Meysam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561470/ https://www.ncbi.nlm.nih.gov/pubmed/37807067 http://dx.doi.org/10.1186/s12935-023-03086-3 |
Ejemplares similares
-
Molecular mechanisms of microRNA-216a during tumor progression
por: Hamidi, Amir Abbas, et al.
Publicado: (2023) -
MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis
por: Taghehchian, Negin, et al.
Publicado: (2023) -
Molecular mechanisms of the microRNA-132 during tumor progressions
por: Moghbeli, Meysam, et al.
Publicado: (2021) -
MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023) -
MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)